Wordt geladen...
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Most academic precision oncology programs have been designed to facilitate enrollment of patients in early clinical trials with matched targeted agents. Over the last decade, major changes were seen both in the targetable molecular alteration landscape and in drug development trends. In this article...
Bewaard in:
| Gepubliceerd in: | JCO Precis Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446427/ https://ncbi.nlm.nih.gov/pubmed/32923891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00398 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|